Skip to content

Dr. Charlotte De Clercq

Active Private limited companyfounded 2023active for 3 yearsFazantenstraat 2, 8530 HarelbekeKBO/BCE: BE 0802.075.578

Lifetime

2 annual accounts with figures on one time axis
peak of €131,546 in 2025
€131,546▲ 78.0%
peak of €99,265 in 2025
€99,265▲ 74.3%
peak of €157,201 in 2025
€157,201▲ 171%
€78,009▼ 17.2%
Board1 name since 2023
1 director
Documentsfilings and deeds
26-03-202635 days before the deadline
2025micro format
Gross margin from €73,891 to €131,546Result from €56,936 to €99,265Equity from €57,936 to €157,201Debts from €94,239 to €78,009Investments €12,982Cash from €57,361 to €167,910

Key points

from the 2025 annual accounts

Equity

€157,201 ▲ 171%
€57,9002024€157,0002025

Equity rose in 2025 from €57,936 to €157,201.

Investments

€15,109 4.5 times depreciation
20242025

Green is investment, beige is depreciation.

Liquidity

2.78 was 1.51 in 2024

Short-term debts fell from €93,231 to €77,001.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,332 companies had the same profile as Dr. Charlotte De Clercq has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,332 companies, not a prediction for Dr. Charlotte De Clercq. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 50 sharesdeed of 26-05-2023
  • 50 sharesdeed of 26-05-2023
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0802075578
First establishment Fazantenstraat 2, Harelbeke
Incorporation Founding capital of €1,000, 50 shares · Founded by · appointed as director · published on 26-05-2023 · Gazette deed
All 6 events

Comparable companies

same main activity, similar in size and age
Company
Dr. Charlotte De Clercq Harelbeke €235,210 €131,546 66.8% -
DOKTER ANNELIES VANTOMME Wingene €227,274 €132,269 78.7% -
DR. JARI DELBAERE Menen €245,745 €135,711 81.2% -
DR. SVEN VERSCHUERE Waregem €265,953 €138,427 77.6% -
Dokter Vandeputte Els Kortemark €215,964 €146,473 96.8% -
DR. L. VANDER STICHELE Roeselare €195,036 €132,852 75.6% -
BENA MEDICAL Forest €247,687 €131,171 93.9% -

These companies have the same main activity as Dr. Charlotte De Clercq: general medical practice (NACE 86210). They are comparable in size and age: total assets between €195,000 and €266,000, founded in 2023.

Official details

Source: KBO
Status
Active since 24-05-2023Normal situation
Activity
General medical practiceNACE 86210and 1 other
Establishment unit
2.350.417.8868530 Harelbeke, since 01-10-2023
Financial year end
30 September
Peppol
Reachable since 28-11-2024
Company details

Annual accounts to 30-09-2025

≈ €240,000estimated
€235,210▲ 54.6%
Filing
Filed on 26-03-2026, 35 days before the end of the filing period
Financials

Insights on Dr. Charlotte De Clercq

Dr. Charlotte De Clercq has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €157,201 and a net result of €99,265.

Its solvency ranks better than 54% of 21,373 sector peers (NACE 86) in financial year 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. Charlotte De Clercq

What is the company number of Dr. Charlotte De Clercq?
The company number of Dr. Charlotte De Clercq is 0802.075.578. The VAT number is the same number with BE in front: BE 0802.075.578.
Where is Dr. Charlotte De Clercq based?
The registered office is at Fazantenstraat 2, 8530 Harelbeke.Company details
What does Dr. Charlotte De Clercq do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. Charlotte De Clercq?
Dr. Charlotte De Clercq is a private limited company (BV).
When was Dr. Charlotte De Clercq founded?
Dr. Charlotte De Clercq was founded on 24-05-2023.
Is Dr. Charlotte De Clercq still active?
Yes, Dr. Charlotte De Clercq is an active enterprise in the KBO register.
What is the turnover of Dr. Charlotte De Clercq?
The turnover in financial year 2025 is about €240,000. This figure is estimated from the gross margin of €131,546 and 30 comparable companies (NACE 86210). It probably lies between €190,000 and €300,000.Financials
Is Dr. Charlotte De Clercq profitable?
In financial year 2025, Dr. Charlotte De Clercq made a profit of €99,265.
Where can I find the annual accounts of Dr. Charlotte De Clercq?
Dr. Charlotte De Clercq filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Charlotte De Clercq due?
Dr. Charlotte De Clercq must file the annual accounts for financial year 2026 by 30-04-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.